-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22

Benzinga·11/06/2026 16:26:43
Listen to the news
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $24 to $22.